Evidence map›Paper›PMID 42490856›Full record

ArticleFrontiers in oncology2026

Case Report: Spectral CT characterization of giant esophageal schwannoma with reactive lymphoid hyperplasia mimicking lymphoproliferative disease.

Zuyi Fan, Anqi Zhang, Yumeng Xi, Meng Wang, Zhenzhen Fan, Zhihui Dong

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zuyi FanDivision of Graduate, Henan Medical University, Xinxiang, China.
Anqi ZhangDivision of Graduate, Henan Medical University, Xinxiang, China.
Yumeng XiDepartment of Imaging, Luoyang Central Hospital, Luoyang, China.
Meng WangDepartment of Pathology, Luoyang Central Hospital, Luoyang, China.
Zhenzhen FanDepartment of Imaging, Luoyang Central Hospital, Luoyang, China.
Zhihui DongDivision of Graduate, Henan Medical University, Xinxiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Esophageal schwannoma is an uncommon mesenchymal tumor that is frequently misdiagnosed before surgery because its clinical and radiological appearances overlap with those of other submucosal esophageal tumors and mediastinal masses. We report a 48-year-old woman with mild dysphagia and an incidentally detected right mediastinal mass. Spectral computed tomography (CT) demonstrated an 83 × 63 × 100 mm upper-to-middle thoracic esophageal submucosal mass with an intraluminal air crescent sign, heterogeneous enhancement, and multiple enlarged mediastinal and perigastric lymph nodes. Compared to conventional contrast-enhanced CT, low-energy 45-keV monoenergetic images and iodine-based spectral parameters yielded higher absolute attenuation values, objectively characterizing the heterogeneous intratumoral enhancement and demonstrating spectral differences between the primary mass and lymph nodes. Endoscopy confirmed a long submucosal elevated lesion with a localized ulcer, bronchoscopy showed extrinsic airway compression, and barium esophagography revealed a smooth filling defect. Partial esophagectomy was performed because of the tumor size and its proximity to an aberrant right subclavian artery and the brachiocephalic trunk. Due to the unachievable complete en bloc resection, the macroscopic residual mass was successfully managed with targeted adjuvant radiotherapy. Histopathology revealed a spindle-cell tumor with a prominent peripheral lymphoid cuff. To avoid diagnostic ambiguity, immunohistochemical profiling was stratified: the spindle cells were positive for S-100 and vimentin, and negative for SMA, desmin, and DOG-1, which confirmed schwannoma and excluded gastrointestinal stromal tumor. The surrounding reactive lymphoid component specifically exhibited B-cell markers.

Indexed as

dual-energy CTesophageal schwannomareactive lymphadenopathyspectral CTsubmucosal esophageal tumor

Identifiers

PMID42490856
PMCPMC13375467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.